Compile Data Set for Download or QSAR
maximum 50k data
Found 445 Enz. Inhib. hit(s) with all data for entry = 9995
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506557(US11045457, Example 157)
Affinity DataIC50:  1.58nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506586(US11045457, Example 187)
Affinity DataIC50:  3.98nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506515(US11045457, Example 115)
Affinity DataIC50:  5.01nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506558(US11045457, Example 158)
Affinity DataIC50:  7.94nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506504(US11045457, Example 104)
Affinity DataIC50:  10nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506544(US11045457, Example 144)
Affinity DataIC50:  10nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506510(US11045457, Example 110 | US11045457, Example 145)
Affinity DataIC50:  15.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506502(US11045457, Example 102)
Affinity DataIC50:  15.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506430(US11045457, Example 30)
Affinity DataIC50:  15.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506593(US11045457, Example 194)
Affinity DataIC50:  20nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506615(US11045457, Example 216)
Affinity DataIC50:  20nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506428(US11045457, Example 28)
Affinity DataIC50:  20nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506561(US11045457, Example 161)
Affinity DataIC50:  20nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506507(US11045457, Example 107)
Affinity DataIC50:  20nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506612(US11045457, Example 213)
Affinity DataIC50:  25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506609(US11045457, Example 210)
Affinity DataIC50:  25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506608(US11045457, Example 209)
Affinity DataIC50:  25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506606(US11045457, Example 207)
Affinity DataIC50:  25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506427(US11045457, Example 27)
Affinity DataIC50:  25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506470(US11045457, Example 70)
Affinity DataIC50:  25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506589(US11045457, Example 190)
Affinity DataIC50:  25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506587(US11045457, Example 188)
Affinity DataIC50:  25.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506595(US11045457, Example 196)
Affinity DataIC50:  31.6nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506547(US11045457, Example 147)
Affinity DataIC50:  31.6nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506413(BDBM506508 | US11045457, Example 13)
Affinity DataIC50:  31.6nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506566(US11045457, Example 166)
Affinity DataIC50:  39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506467(US11045457, Example 67)
Affinity DataIC50:  39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506429(US11045457, Example 29)
Affinity DataIC50:  39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506579(US11045457, Example 179)
Affinity DataIC50:  39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506585(US11045457, Example 186)
Affinity DataIC50:  39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506524(US11045457, Example 124)
Affinity DataIC50:  39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506611(US11045457, Example 212)
Affinity DataIC50:  39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506548(US11045457, Example 148)
Affinity DataIC50:  39.8nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506519(US11045457, Example 119)
Affinity DataIC50:  50.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506426(US11045457, Example 26)
Affinity DataIC50:  50.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506550(US11045457, Example 150)
Affinity DataIC50:  50.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506471(US11045457, Example 71)
Affinity DataIC50:  50.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506525(US11045457, Example 125)
Affinity DataIC50:  50.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506538(US11045457, Example 138)
Affinity DataIC50:  63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506539(US11045457, Example 139 | US11045457, Example 177)
Affinity DataIC50:  63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506416(US11045457, Example 16)
Affinity DataIC50:  63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506420(US11045457, Example 20)
Affinity DataIC50:  63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506528(US11045457, Example 128)
Affinity DataIC50:  63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506555(US11045457, Example 155)
Affinity DataIC50:  63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506505(US11045457, Example 105)
Affinity DataIC50:  63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506469(US11045457, Example 69)
Affinity DataIC50:  63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506610(US11045457, Example 211)
Affinity DataIC50:  63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506523(US11045457, Example 123)
Affinity DataIC50:  63.1nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506472(US11045457, Example 72)
Affinity DataIC50:  79.4nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506447(US11045457, Example 47)
Affinity DataIC50:  79.4nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 445 total ) | Next | Last >>
Jump to: